Tumor Control by Manipulation of the Human Anti-Apoptotic Survivin Gene

Author(s): Zakir Khan, Pratiksha Bhadouria, Radha Gupta, Prakash S. Bisen

Journal Name: Current Cancer Therapy Reviews

Volume 2 , Issue 1 , 2006

Become EABM
Become Reviewer


Survivin is a relatively unique member of the inhibitor of apoptosis protein (IAP) family. It contains a single baculovirus IAP repeat (BIR) domain. It is involved in the control of cell cycle and inhibition of apoptosis. Survivin is of interest because it is specifically up-regulated in cancer cells and completely down-regulated and undetectable in normal adult tissues. Thus, survivin has proved to be a promising therapeutic target for normal anti-cancer therapy. Survivin protects the fast dividing tumor cells against default apoptosis to facilitate aberrant mitosis. Down-regulation of survivin with multiple approaches, suppress tumor progression and induce apoptosis on its own or in combination with chemotherapy and radiotherapy.

Keywords: Survivin, IAPs, Apoptosis, Caspases, Ribozyme, p53

promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Page: [73 - 79]
Pages: 7
DOI: 10.2174/157339406777592113

Article Metrics

PDF: 34